Smart patch vs finger prick: can a CGM improve blood sugar after Weight-Loss surgery?

NCT ID NCT07095972

Not yet recruiting Disease control Sponsor: Pennington Biomedical Research Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 10, 2026 · Updated 3 times

Summary

This study will enroll 20 severely obese adults scheduled for metabolic surgery. Half will use a continuous glucose monitor (CGM) and half will use standard finger-stick testing to track blood sugar. Researchers want to see if the CGM leads to steadier blood sugar levels and fewer dangerous lows. The goal is to find better ways to manage glucose after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Abbott Freestyle Libre CGM (continuous glucose monitor device)
What this could lead to: If successful, this could show that using a CGM helps people with obesity achieve better blood sugar control after metabolic surgery compared to standard finger-stick testing.
What could go wrong: This is a very small early-stage trial with only 20 participants, so results may not apply to everyone. The device is for monitoring only and does not directly treat obesity or diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus morbid obesity Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES OBESITY (DISORDER)

Contacts and locations

Locations

Pennington Biomedical Research Center

Baton Rouge, Louisiana, 70808, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.